カテゴリー：世界, 医療/バイオ, LP Information

世界の抗勃起不全（ED）薬市場予測 2023年-2029年

【英語タイトル】Global Anti-erectile Dysfunction (ED) Drugs Market Growth 2023-2029
	・商品コード：LP23DC08387 ・発行会社（調査会社）：LP Information ・発行日：2023年11月・ページ数：116 ・レポート言語：英語・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日）・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など・産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の抗勃起不全（ED）薬市場」は、過去の販売実績から2022年の世界の抗勃起不全（ED）薬の総販売量を検討し、2023年から2029年の予測される抗勃起不全（ED）薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗勃起不全（ED）薬の市場規模を掲載し、XXX百万米ドル規模の世界の抗勃起不全（ED）薬市場の詳細な分析を提供します。本インサイトレポートは、世界の抗勃起不全（ED）薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の抗勃起不全（ED）薬市場における各社の独自のポジションをより深く理解するために、抗勃起不全（ED）薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の抗勃起不全（ED）薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗勃起不全（ED）薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。抗勃起不全（ED）薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗勃起不全（ED）薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

抗勃起不全（ED）薬の世界主要メーカーとしては、Vivus, Inc.、 Lilly ICOS LLC、 Pfizer、 Bayer、 Hims、 Menarini Group、 Lupin、 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、 General Factory、 CSBio、 Dong-A ST、 Metuchen Pharma、 Seoul Pharma、 Teva Pharma、 S.K. Chemicalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の抗勃起不全（ED）薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では抗勃起不全（ED）薬市場をセグメンテーションし、種類別 (シルデナフィル（バイアグラ）、バルデナフィル（レビトラ、スタキシン）、タダラフィル（シアリス）、アバナフィル（ステンドラ）、ウデナフィル（ザイデナ）、その他)、用途別 (病院、小売薬局、診療所、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：シルデナフィル（バイアグラ）、バルデナフィル（レビトラ、スタキシン）、タダラフィル（シアリス）、アバナフィル（ステンドラ）、ウデナフィル（ザイデナ）、その他

・用途別区分：病院、小売薬局、診療所、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の抗勃起不全（ED）薬市場の10年間の市場状況・展望は？
・世界および地域別に見た抗勃起不全（ED）薬市場成長の要因は何か？
・抗勃起不全（ED）薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・抗勃起不全（ED）薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：抗勃起不全（ED）薬の年間販売量2018-2029、地域別現状・将来分析
・抗勃起不全（ED）薬の種類別セグメント：シルデナフィル（バイアグラ）、バルデナフィル（レビトラ、スタキシン）、タダラフィル（シアリス）、アバナフィル（ステンドラ）、ウデナフィル（ザイデナ）、その他
・抗勃起不全（ED）薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・抗勃起不全（ED）薬の用途別セグメント：病院、小売薬局、診療所、オンライン薬局
・抗勃起不全（ED）薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の抗勃起不全（ED）薬市場
・企業別のグローバル抗勃起不全（ED）薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の抗勃起不全（ED）薬の年間売上：2018-2023年の売上、市場シェア
・企業別の抗勃起不全（ED）薬販売価格
・主要企業の抗勃起不全（ED）薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

抗勃起不全（ED）薬の地域別レビュー
・地域別の抗勃起不全（ED）薬市場規模2018-2023：年間販売量、売上
・主要国別の抗勃起不全（ED）薬市場規模2018-2023：年間販売量、売上
・南北アメリカの抗勃起不全（ED）薬販売の成長
・アジア太平洋の抗勃起不全（ED）薬販売の成長
・ヨーロッパの抗勃起不全（ED）薬販売の成長
・中東・アフリカの抗勃起不全（ED）薬販売の成長

南北アメリカ市場
・南北アメリカの国別の抗勃起不全（ED）薬販売量、売上（2018-2023）
・南北アメリカの抗勃起不全（ED）薬の種類別販売量
・南北アメリカの抗勃起不全（ED）薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の抗勃起不全（ED）薬販売量、売上（2018-2023）
・アジア太平洋の抗勃起不全（ED）薬の種類別販売量
・アジア太平洋の抗勃起不全（ED）薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の抗勃起不全（ED）薬販売量、売上（2018-2023）
・ヨーロッパの抗勃起不全（ED）薬の種類別販売量
・ヨーロッパの抗勃起不全（ED）薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の抗勃起不全（ED）薬販売量、売上（2018-2023）
・中東・アフリカの抗勃起不全（ED）薬の種類別販売量
・中東・アフリカの抗勃起不全（ED）薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・抗勃起不全（ED）薬の製造コスト構造分析
・抗勃起不全（ED）薬の製造プロセス分析
・抗勃起不全（ED）薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・抗勃起不全（ED）薬の主要なグローバル販売業者
・抗勃起不全（ED）薬の主要なグローバル顧客

地域別の抗勃起不全（ED）薬市場予測レビュー
・地域別の抗勃起不全（ED）薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・抗勃起不全（ED）薬の種類別市場規模予測
・抗勃起不全（ED）薬の用途別市場規模予測

主要企業分析
Vivus, Inc.、 Lilly ICOS LLC、 Pfizer、 Bayer、 Hims、 Menarini Group、 Lupin、 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、 General Factory、 CSBio、 Dong-A ST、 Metuchen Pharma、 Seoul Pharma、 Teva Pharma、 S.K. Chemicals
・企業情報
・抗勃起不全（ED）薬製品
・抗勃起不全（ED）薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Anti-erectile Dysfunction (ED) Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-erectile Dysfunction (ED) Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-erectile Dysfunction (ED) Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-erectile Dysfunction (ED) Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-erectile Dysfunction (ED) Drugs players cover Vivus, Inc., Lilly ICOS LLC, Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd and General Factory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Anti-erectile Dysfunction (ED) Drugs Industry Forecast” looks at past sales and reviews total world Anti-erectile Dysfunction (ED) Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-erectile Dysfunction (ED) Drugs sales for 2023 through 2029. With Anti-erectile Dysfunction (ED) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-erectile Dysfunction (ED) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-erectile Dysfunction (ED) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-erectile Dysfunction (ED) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-erectile Dysfunction (ED) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-erectile Dysfunction (ED) Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-erectile Dysfunction (ED) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-erectile Dysfunction (ED) Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Sildenafil (Viagra)
Vardenafil (Levitra, Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
Segmentation by application
Hospital
Retail Pharmacy
Clinic
Online Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Vivus, Inc.
Lilly ICOS LLC
Pfizer
Bayer
Hims
Menarini Group
Lupin
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
General Factory
CSBio
Dong-A ST
Metuchen Pharma
Seoul Pharma
Teva Pharma
S.K. Chemicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-erectile Dysfunction (ED) Drugs market?
What factors are driving Anti-erectile Dysfunction (ED) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-erectile Dysfunction (ED) Drugs market opportunities vary by end market size?
How does Anti-erectile Dysfunction (ED) Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-erectile Dysfunction (ED) Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-erectile Dysfunction (ED) Drugs by Country/Region, 2018, 2022 & 2029
2.2 Anti-erectile Dysfunction (ED) Drugs Segment by Type
2.2.1 Sildenafil (Viagra)
2.2.2 Vardenafil (Levitra, Staxyn)
2.2.3 Tadalafil (Cialis)
2.2.4 Avanafil (Stendra)
2.2.5 Udenafil (Zydena)
2.2.6 Others
2.3 Anti-erectile Dysfunction (ED) Drugs Sales by Type
2.3.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Type (2018-2023)
2.4 Anti-erectile Dysfunction (ED) Drugs Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Clinic
2.4.4 Online Pharmacy
2.5 Anti-erectile Dysfunction (ED) Drugs Sales by Application
2.5.1 Global Anti-erectile Dysfunction (ED) Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Application (2018-2023)
3 Global Anti-erectile Dysfunction (ED) Drugs by Company
3.1 Global Anti-erectile Dysfunction (ED) Drugs Breakdown Data by Company
3.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company (2018-2023)
3.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2018-2023)
3.2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Company
3.4 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Product Location Distribution
3.4.2 Players Anti-erectile Dysfunction (ED) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-erectile Dysfunction (ED) Drugs by Geographic Region
4.1 World Historic Anti-erectile Dysfunction (ED) Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-erectile Dysfunction (ED) Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-erectile Dysfunction (ED) Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.4 APAC Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.5 Europe Anti-erectile Dysfunction (ED) Drugs Sales Growth
4.6 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Growth
5 Americas
5.1 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country
5.1.1 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country (2018-2023)
5.1.2 Americas Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2018-2023)
5.2 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Type
5.3 Americas Anti-erectile Dysfunction (ED) Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region
6.1.1 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region (2018-2023)
6.1.2 APAC Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2018-2023)
6.2 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Type
6.3 APAC Anti-erectile Dysfunction (ED) Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-erectile Dysfunction (ED) Drugs by Country
7.1.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2018-2023)
7.1.2 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2018-2023)
7.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type
7.3 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs by Country
8.1.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Type
8.3 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs
10.3 Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
10.4 Industry Chain Structure of Anti-erectile Dysfunction (ED) Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-erectile Dysfunction (ED) Drugs Distributors
11.3 Anti-erectile Dysfunction (ED) Drugs Customer
12 World Forecast Review for Anti-erectile Dysfunction (ED) Drugs by Geographic Region
12.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size Forecast by Region
12.1.1 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Region (2024-2029)
12.1.2 Global Anti-erectile Dysfunction (ED) Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Type
12.7 Global Anti-erectile Dysfunction (ED) Drugs Forecast by Application
13 Key Players Analysis
13.1 Vivus, Inc.
13.1.1 Vivus, Inc. Company Information
13.1.2 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Vivus, Inc. Main Business Overview
13.1.5 Vivus, Inc. Latest Developments
13.2 Lilly ICOS LLC
13.2.1 Lilly ICOS LLC Company Information
13.2.2 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lilly ICOS LLC Main Business Overview
13.2.5 Lilly ICOS LLC Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Hims
13.5.1 Hims Company Information
13.5.2 Hims Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hims Main Business Overview
13.5.5 Hims Latest Developments
13.6 Menarini Group
13.6.1 Menarini Group Company Information
13.6.2 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Menarini Group Main Business Overview
13.6.5 Menarini Group Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
13.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
13.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business Overview
13.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
13.9 General Factory
13.9.1 General Factory Company Information
13.9.2 General Factory Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 General Factory Main Business Overview
13.9.5 General Factory Latest Developments
13.10 CSBio
13.10.1 CSBio Company Information
13.10.2 CSBio Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 CSBio Main Business Overview
13.10.5 CSBio Latest Developments
13.11 Dong-A ST
13.11.1 Dong-A ST Company Information
13.11.2 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Dong-A ST Main Business Overview
13.11.5 Dong-A ST Latest Developments
13.12 Metuchen Pharma
13.12.1 Metuchen Pharma Company Information
13.12.2 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Metuchen Pharma Main Business Overview
13.12.5 Metuchen Pharma Latest Developments
13.13 Seoul Pharma
13.13.1 Seoul Pharma Company Information
13.13.2 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Seoul Pharma Main Business Overview
13.13.5 Seoul Pharma Latest Developments
13.14 Teva Pharma
13.14.1 Teva Pharma Company Information
13.14.2 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Teva Pharma Main Business Overview
13.14.5 Teva Pharma Latest Developments
13.15 S.K. Chemicals
13.15.1 S.K. Chemicals Company Information
13.15.2 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
13.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 S.K. Chemicals Main Business Overview
13.15.5 S.K. Chemicals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anti-erectile Dysfunction (ED) Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-erectile Dysfunction (ED) Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Sildenafil (Viagra)
Table 4. Major Players of Vardenafil (Levitra, Staxyn)
Table 5. Major Players of Tadalafil (Cialis)
Table 6. Major Players of Avanafil (Stendra)
Table 7. Major Players of Udenafil (Zydena)
Table 8. Major Players of Others
Table 9. Global Anti-erectile Dysfunction (ED) Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2018-2023)
Table 11. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Anti-erectile Dysfunction (ED) Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2018-2023)
Table 16. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2018-2023)
Table 17. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Anti-erectile Dysfunction (ED) Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company (2018-2023)
Table 21. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global Anti-erectile Dysfunction (ED) Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Producing Area Distribution and Sales Area
Table 25. Players Anti-erectile Dysfunction (ED) Drugs Products Offered
Table 26. Anti-erectile Dysfunction (ED) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Anti-erectile Dysfunction (ED) Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Anti-erectile Dysfunction (ED) Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas Anti-erectile Dysfunction (ED) Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC Anti-erectile Dysfunction (ED) Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Anti-erectile Dysfunction (ED) Drugs
Table 62. Key Market Challenges & Risks of Anti-erectile Dysfunction (ED) Drugs
Table 63. Key Industry Trends of Anti-erectile Dysfunction (ED) Drugs
Table 64. Anti-erectile Dysfunction (ED) Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Anti-erectile Dysfunction (ED) Drugs Distributors List
Table 67. Anti-erectile Dysfunction (ED) Drugs Customer List
Table 68. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Anti-erectile Dysfunction (ED) Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Anti-erectile Dysfunction (ED) Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Vivus, Inc. Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 84. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Vivus, Inc. Main Business
Table 86. Vivus, Inc. Latest Developments
Table 87. Lilly ICOS LLC Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 89. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Lilly ICOS LLC Main Business
Table 91. Lilly ICOS LLC Latest Developments
Table 92. Pfizer Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 94. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Bayer Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 99. Bayer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. Hims Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Hims Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 104. Hims Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Hims Main Business
Table 106. Hims Latest Developments
Table 107. Menarini Group Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 109. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Menarini Group Main Business
Table 111. Menarini Group Latest Developments
Table 112. Lupin Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Lupin Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 114. Lupin Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Lupin Main Business
Table 116. Lupin Latest Developments
Table 117. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 119. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business
Table 121. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
Table 122. General Factory Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. General Factory Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 124. General Factory Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. General Factory Main Business
Table 126. General Factory Latest Developments
Table 127. CSBio Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. CSBio Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 129. CSBio Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. CSBio Main Business
Table 131. CSBio Latest Developments
Table 132. Dong-A ST Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 134. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Dong-A ST Main Business
Table 136. Dong-A ST Latest Developments
Table 137. Metuchen Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 139. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Metuchen Pharma Main Business
Table 141. Metuchen Pharma Latest Developments
Table 142. Seoul Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 144. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Seoul Pharma Main Business
Table 146. Seoul Pharma Latest Developments
Table 147. Teva Pharma Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 149. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Teva Pharma Main Business
Table 151. Teva Pharma Latest Developments
Table 152. S.K. Chemicals Basic Information, Anti-erectile Dysfunction (ED) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Portfolios and Specifications
Table 154. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. S.K. Chemicals Main Business
Table 156. S.K. Chemicals Latest Developments
List of Figures
Figure 1. Picture of Anti-erectile Dysfunction (ED) Drugs
Figure 2. Anti-erectile Dysfunction (ED) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-erectile Dysfunction (ED) Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-erectile Dysfunction (ED) Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-erectile Dysfunction (ED) Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Sildenafil (Viagra)
Figure 10. Product Picture of Vardenafil (Levitra, Staxyn)
Figure 11. Product Picture of Tadalafil (Cialis)
Figure 12. Product Picture of Avanafil (Stendra)
Figure 13. Product Picture of Udenafil (Zydena)
Figure 14. Product Picture of Others
Figure 15. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type in 2022
Figure 16. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2018-2023)
Figure 17. Anti-erectile Dysfunction (ED) Drugs Consumed in Hospital
Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Market: Hospital (2018-2023) & (K Units)
Figure 19. Anti-erectile Dysfunction (ED) Drugs Consumed in Retail Pharmacy
Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 21. Anti-erectile Dysfunction (ED) Drugs Consumed in Clinic
Figure 22. Global Anti-erectile Dysfunction (ED) Drugs Market: Clinic (2018-2023) & (K Units)
Figure 23. Anti-erectile Dysfunction (ED) Drugs Consumed in Online Pharmacy
Figure 24. Global Anti-erectile Dysfunction (ED) Drugs Market: Online Pharmacy (2018-2023) & (K Units)
Figure 25. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2022)
Figure 26. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application in 2022
Figure 27. Anti-erectile Dysfunction (ED) Drugs Sales Market by Company in 2022 (K Units)
Figure 28. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Company in 2022
Figure 29. Anti-erectile Dysfunction (ED) Drugs Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company in 2022
Figure 31. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Anti-erectile Dysfunction (ED) Drugs Sales 2018-2023 (K Units)
Figure 34. Americas Anti-erectile Dysfunction (ED) Drugs Revenue 2018-2023 ($ Millions)
Figure 35. APAC Anti-erectile Dysfunction (ED) Drugs Sales 2018-2023 (K Units)
Figure 36. APAC Anti-erectile Dysfunction (ED) Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Europe Anti-erectile Dysfunction (ED) Drugs Sales 2018-2023 (K Units)
Figure 38. Europe Anti-erectile Dysfunction (ED) Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2022
Figure 42. Americas Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country in 2022
Figure 43. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2018-2023)
Figure 44. Americas Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2018-2023)
Figure 45. United States Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region in 2022
Figure 50. APAC Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Regions in 2022
Figure 51. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2018-2023)
Figure 52. APAC Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2018-2023)
Figure 53. China Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2022
Figure 61. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country in 2022
Figure 62. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2018-2023)
Figure 63. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2018-2023)
Figure 64. Germany Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2018-2023)
Figure 73. Egypt Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Anti-erectile Dysfunction (ED) Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs in 2022
Figure 79. Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
Figure 80. Industry Chain Structure of Anti-erectile Dysfunction (ED) Drugs
Figure 81. Channels of Distribution
Figure 82. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Forecast by Region (2024-2029)
Figure 83. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share Forecast by Application (2024-2029)

★調査レポート[世界の抗勃起不全（ED）薬市場予測 2023年-2029年] (コード：LP23DC08387)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の抗勃起不全（ED）薬市場予測 2023年-2029年]についてメールでお問い合わせ

MarketReport.jp

世界の抗勃起不全（ED）薬市場予測 2023年-2029年

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp